IN2013MU03098A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03098A
IN2013MU03098A IN3098MU2013A IN2013MU03098A IN 2013MU03098 A IN2013MU03098 A IN 2013MU03098A IN 3098MU2013 A IN3098MU2013 A IN 3098MU2013A IN 2013MU03098 A IN2013MU03098 A IN 2013MU03098A
Authority
IN
India
Prior art keywords
percent
weight
mannitol
paracetamol
tramadol hydrochloride
Prior art date
Application number
Other languages
English (en)
Inventor
Mahendra B Chaudhari Mr
Jagdish S Wadhwani Mr
Original Assignee
Athena Drug Delivery Solutions Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Athena Drug Delivery Solutions Pvt Ltd filed Critical Athena Drug Delivery Solutions Pvt Ltd
Priority to PCT/IN2014/000568 priority Critical patent/WO2015044952A2/en
Priority to IN3098MU2013 priority patent/IN2013MU03098A/en
Priority to EP14849334.9A priority patent/EP3052089B1/en
Publication of IN2013MU03098A publication Critical patent/IN2013MU03098A/en
Priority to ZA2016/01750A priority patent/ZA201601750B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3098MU2013 2013-09-30 2014-09-01 IN2013MU03098A (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PCT/IN2014/000568 WO2015044952A2 (en) 2013-09-30 2014-09-01 Tramadol hydrochloride and paracetamol orally disintegrating composition and process for preparing the same
IN3098MU2013 IN2013MU03098A (ko) 2013-09-30 2014-09-01
EP14849334.9A EP3052089B1 (en) 2013-09-30 2014-09-01 Tramadol hydrochloride and paracetamol orally disintegrating composition and process for preparing the same
ZA2016/01750A ZA201601750B (en) 2013-09-30 2016-03-14 Tramadol hydrochloride and paracetamol orally disintegrating composition and process for preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3098MU2013 IN2013MU03098A (ko) 2013-09-30 2014-09-01

Publications (1)

Publication Number Publication Date
IN2013MU03098A true IN2013MU03098A (ko) 2015-07-17

Family

ID=52744635

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3098MU2013 IN2013MU03098A (ko) 2013-09-30 2014-09-01

Country Status (4)

Country Link
EP (1) EP3052089B1 (ko)
IN (1) IN2013MU03098A (ko)
WO (1) WO2015044952A2 (ko)
ZA (1) ZA201601750B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111751470B (zh) * 2020-07-07 2023-05-05 多多药业有限公司 一种盐酸曲马多制剂中的新杂质的检测控制方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1028176C (zh) 1992-08-20 1995-04-12 中国原子能科学研究院 不锈钢防氚渗透材料的制作工艺
WO2004026308A1 (fr) * 2002-09-21 2004-04-01 Shuyi Zhang Compose d'acetamidophenol et de tramadol a liberation prolongee
FR2855756B1 (fr) * 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
CN100404025C (zh) * 2005-01-14 2008-07-23 信谊药厂 含有盐酸曲马多和对乙酰氨基酚的口崩片及其制备方法
CN100364519C (zh) * 2005-08-22 2008-01-30 南京海陵中药制药工艺技术研究有限公司 氨酚曲马多咀嚼片及其制备方法
CN100496477C (zh) * 2005-09-30 2009-06-10 周卓和 复方盐酸曲马多制剂及其制备方法
EP2362768B1 (en) * 2008-10-27 2016-04-20 Alza Corporation Extended release oral acetaminophen/tramadol dosage form

Also Published As

Publication number Publication date
WO2015044952A3 (en) 2015-06-04
EP3052089B1 (en) 2017-08-30
ZA201601750B (en) 2017-08-30
EP3052089A4 (en) 2016-08-10
WO2015044952A2 (en) 2015-04-02
EP3052089A2 (en) 2016-08-10

Similar Documents

Publication Publication Date Title
PH12016500499B1 (en) Therapeutic polymeric nanoparticles and methods of making and using same
EA201690962A1 (ru) Составы
PH12015502116A1 (en) Biaryl amide compounds as kinase inhibitors
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
MX2013006911A (es) Peliculas sub-linguales.
EP2588099A4 (en) METHOD OF TREATING THE RESTLESS LEG SYNDROME
MX366003B (es) Metabolitos de n-(4-{[6,7-bis(metiloxi)quinolin-4-il]oxi}fenil)-n' -(4-fluorofenil)ciclopropan-1,1-dicarboxamida.
WO2014093583A3 (en) Synthetic methods for preparing 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride, other salt forms of this compound and intermediates thereof
CL2012002540A1 (es) Hidrato de hidrocloruro de agomelatina; forma cristalina; metodo de preparacion; composicion farmaceutica ; y su uso para el tratamiento de trastornos del sueño, estrés, ansiedad, depresion mayor, enfermedades cardiovasculares, entre otras.
MX2017003644A (es) Formulaciones eutecticas de clorhidrato de ciclobenzaprina.
PH12016502246B1 (en) Carboxamide derivatives
PH12018550212A1 (en) Rotigotine behenate and preparation method and use thereof
MX2016014946A (es) Derivados de carboxamida.
EA201892098A1 (ru) Соединение, обладающее ингибирующей мутантную idh активностью, способ его получения и применения
UA107702C2 (en) Novel benzamide derivatives
NZ701103A (en) Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide
IN2013MU03098A (ko)
EA201500669A1 (ru) Офтальмологическая фармацевтическая композиция для наружного применения, содержащая регорафениб
IN2013MU03565A (ko)
IN2013MU03422A (ko)
MX2016004410A (es) Uso de n-(4-terc-butilbencil)-3-cloro-n-[2-(4-cloro-3-etil-fenil)- etil]-2-fluoro-5-trifluorometil-benzamida para el tratamiento de enfermedades oftalmologicas.
WO2014178068A3 (en) An improved process for preparation of n-[1-(1-naphthyl)ethyl] -3- [3-(trifluoromethyl)phenyl]propan-1-amine and pharmaceutically acceptable salts thereof
IN2013MU01760A (ko)
IN2014KN02584A (ko)
IN2013MU01336A (ko)